Neoleukin files corrected Amended and Restated Bylaws to fix table-of-contents errors

Neurogene Inc.

Board adopted amended bylaws on Nov 30, 2022.
Corrected version filed on Jan 7, 2023, fixing incorrect references and page numbers in the table of contents.
Correction addresses clerical errors only; substantive bylaws unchanged.
Corrected bylaws attached as Exhibit 3.1 to this filing.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Neurogene Inc.: Amended and Restated Bylaws corrected incorrect references and page numbers in the table of contents (effective 2023-01-07).

Change: bylaw amendment
Effective: 2023-01-07

Exact text from the filing

On January 7, 2023, the Company filed updated Amended and Restated Bylaws to correct incorrect references and page numbers within the table of contents

View on SEC.gov

49 governance changes filed in the last 30 days. Browse all governance changes →

Neurogene Inc. filing history →

Source: SEC EDGAR

accession 0001628280-23-001398

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.